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Abstract
Large-scale genome-wide association studies (GWAS) have identified many loci associated with body mass index (BMI), but
few studies focused on obesity as a binary trait. Here we report the results of a GWAS and candidate SNP genotyping study
of obesity, including extremely obese cases and never overweight controls as well as families segregating extreme obesity
and thinness. We first performed a GWAS on 520 cases (BMI.35 kg/m
2) and 540 control subjects (BMI,25 kg/m
2), on
measures of obesity and obesity-related traits. We subsequently followed up obesity-associated signals by genotyping the
top ,500 SNPs from GWAS in the combined sample of cases, controls and family members totaling 2,256 individuals. For
the binary trait of obesity, we found 16 genome-wide significant signals within the FTO gene (strongest signal at
rs17817449, P=2.5610
212). We next examined obesity-related quantitative traits (such as total body weight, waist
circumference and waist to hip ratio), and detected genome-wide significant signals between waist to hip ratio and NRXN3
(rs11624704, P=2.67610
29), previously associated with body weight and fat distribution. Our study demonstrated how a
relatively small sample ascertained through extreme phenotypes can detect genuine associations in a GWAS.
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Introduction
Obesity is the sixth most important risk factor contributing to
the overall burden of disease worldwide [1]. Affected subjects have
reduced life expectancy, and they suffer from several adverse
consequences such as cardiovascular disease, type 2 diabetes and
several cancers. Many studies have shown that body weight and
obesity are strongly influenced by genetic factors, with heritability
estimates in the range of 65–80% [2,3]. Genetic variants in several
genes are known to influence BMI, but these mutations are rare
and often cause severe monogenic syndromes with obesity [4].
With the development of high-throughput genotyping techniques
and the implementation of genome-wide association studies
(GWAS), common variations, such as those in FTO [5] and
MC4R [6], have been associated with obesity and body mass index
(BMI). Recent large-scale meta-analysis of multiple GWAS
identified additional genes harboring common SNPs that associate
with BMI [7–10]. GWASs have also found associations with
measures of body fat distribution [9,11,12]. By far the largest
GWAS to date included almost 250 thousand individuals and 2.8
million SNPs [13]. Associations of BMI with 28 loci reached
genome wide significance, including 10 that were reported
previously and 18 that were newly identified. Four additional loci
were associated with body fat distribution, all of which had been
identified previously. However, even this major expansion of
sample size has not explained much variation, 1.39% for BMI and
0.16% for body fat distribution. On the other hand, confirmation
of existing BMI loci, and detailed analysis on their association with
obesity as a binary trait and with other obesity-related quantitative
traits, are important at the current stage to move GWAS signals
forward and understand their functional consequences.
A few studies utilized samples with early-onset or morbid obesity
for discovery, and replicated previously reported association
signals on BMI [7,14–16], or implicated specific genetic variants
such as a recurrent 16p11.2 deletion [17]. Utilizing extreme
phenotypes increases the odds ratio of association, with improved
power to identify novel association signals under fixed genotyping
budgets and fixed sample sizes. We have collected a large cohort of
obese cases and families ascertained from tails of BMI distribution
together with detailed phenotype measures on multiple obesity-
related traits. In addition, we have adult controls who have never
been overweight. However, given fixed genotyping budget, instead
of genotyping all these samples by whole-genome SNP arrays, we
elected to perform a case-control GWAS, and then follow up the
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18939top signals by candidate SNP genotyping on the entire set of
samples including family members. Therefore, the unique dataset
provides an opportunity to examine GWAS associations in a
combined sample of cases, family members, and controls.
Results
We analyzed genotype data for 520 cases and 540 control
subjects, and performed a GWAS on obesity as a binary trait. We
observed a strong association of obesity to the FTO gene, with
the most significantly associated marker being rs3751812
(P=2.01610
28, odds ratio=1.64). All association signals with
P,10
25 are shown in Table 3, and the Manhattan plot is shown
in Figure 1. No additional loci with genome-wide significance
were identified in the GWAS; nevertheless, the fact that FTO
readily reached genome-wide significance in a small data set
confirmed the high quality of the phenotypes within the sample
collection. It also illustrated how a small sample ascertained from
extreme phenotypes have high power to detect genuinely
associated genes, compared to quantitative trait association
analysis conducted on population-based samples.
Considering the possibility that some obesity-associated genes
may be enriched among the top ranked genes in GWAS, we next
followed up selected association signals (,500 top SNPs) by iSelect
genotyping on 2,256 cases, family members and controls.
Additionally, we also performed dense genotyping of 49 SNPs in
the FTO gene itself, including 7 from the original top 500 and 42
spanning the entire gene. We used the MQLS software for the
association analysis, to account for the familial relationships.
Interestingly, the significance for FTO SNPs increased by several
orders of magnitude (P-values range from 10
29 to 10
212),
suggesting that genotyping additional family members increased
power to detect genuine associations (Table 4).
We next completed exploratory analyses of quantitative
measures of obesity. In part because of the extreme bimodality
of the phenotype distributions based on sample ascertainment, we
controlled for case/control status. Moreover, this approach makes
it possible to assess the potential effects of genes on the extent of
obesity in extremely obese individuals. The complete set of results
(P,1610
26) were given in Table 5. We note that a few markers
reached P,5610
28, notably waist circumference (chromosome
21, rs11088859, p=3.75610
28, nearest gene NCAM2), and waist
to hip ratio (chromosome 14, rs11624704, p=2.67610
29, nearest
gene NRXN3), but the NCAM2 locus cannot be regarded as
genome-wide significant considering the need to adjust for
multiple phenotypes being tested. Therefore, these exploratory
results were provided as potentially interesting findings worthy of
additional replication efforts.
Table S1 summarizes our results with respect to previously
reported associations with obesity related traits. As noted, only
FTO and NRXN3 reached genome wide significance. Three genes,
including SH2B1, MC4R and KCTD15, showed trends towards
significance in the case/control association tests (P-value ranges
from 0.015 to 0.065), but they did not pass multiple testing
thresholds (based on number of genes tested). For quantitative
traits, we cannot estimate the power of our study, since previously
published studies utilized population samples for quantitative trait
association with BMI [18]. Nevertheless, in our data, it is
Figure 1. Manhattan plot (logarithm of P-values versus chromosome coordinates) for SNP association on obesity. The FTO locus on
16q12.2 reached genome-wide significance.
doi:10.1371/journal.pone.0018939.g001
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strongest effect sizes (risk allele odds ratio .1.2), probably
explaining why they were the first two genes identified in GWAS
for BMI [5,6].
Discussion
In the current study, we performed a GWAS on obesity and
obesity-related traits. The FTO gene reached genome-wide
significance in this cohort with an odds ratio of 1.6. The MC4R
gene is the second gene found by GWAS to be associated with
BMI [6], and, while only marginally associated with obesity in our
study, its odds ratio was 1.3. Given our modest sample size in
GWAS, we estimate that the power to detect association (with
perfect SNP tagging) at P,5610
28 is 78.8% and 0.18% for FTO
and MC4R, respectively. These odds ratio estimates in our data are
higher than previous reports, for example, odds ratio for FTO is
1.3 in a study for early-onset obesity [5], for FTO and MC4R are
1.46 and 1.02 in a study for extreme obesity [14], or 1.25 and 1.26
in a study on morbidly obese adults with familial obesity [15], or
1.27 and 1.12 for obesity [10]. We note that the Hinney et al
report investigated early onset extreme obesity and reported an
odds ratio of 1.67 for FTO [16], comparable to our study.
Therefore, the increased effect size could be due to the specific
sample ascertainment scheme that we have used, that is, we
sampled from the extreme tails of a quantitative trait distribution
based on BMI. Even with the augmented sample of cases, family
members and controls, no other SNPs reached genome wide
significance. The results therefore strongly suggest that FTO and
MC4R might be the only two major-effect genes for obesity with
Table 1. Sample characteristics of 1,060 cases and controls in
GWAS.
cases N Minimum Maximum Mean SD
488 females 32 males
BMI
1 520 35.57 96.95 49.39 8.78
%FAT 467 30.70 70.70 49.88 6.03
WEIGHT 512 77.05 273.64 138.13 26.91
HEIGHT 509 135.60 198.30 167.07 7.87
WAIST 509 74.40 224.79 122.11 15.32
HIP 509 67.00 276.00 148.49 18.16
WHR 508 0.61 1.46 0.83 0.09
AGE 520 18 64 41.06 9.35
AGEONSET
2 411 .5 55.0 13.63 9.02
controls
532 females 8 males
BMI* 540 15.97 24.93 20.75 1.76
%FAT 530 6.90 40.00 23.70 5.45
WEIGHT 539 37.50 90.00 55.52 6.39
HEIGHT 539 133.90 194.00 163.49 6.53
WAIST 539 40.20 100.00 72.89 5.76
HIP 539 56.90 110.10 86.51 6.51
WHR 538 0.50 1.33 0.84 0.07
AGE 540 16 65 43.10 8.81
1: Self reported maximum BMI were used in 11 cases and 1 control.
2: AGEONSET refers to the age of onset for the obesity diagnosis.
doi:10.1371/journal.pone.0018939.t001
Table 2. Sample characteristics of 2,256 samples in the
candidate SNP genotyping.
N Minimum Maximum Mean SD
Cases
546 females, 37 males
BMI 583 35.08 96.95 49.41 8.81
% FAT 529 30.70 70.70 50.01 5.92
WEIGHT 574 77.05 273.64 138.19 26.62
HEIGHT 571 135.60 198.30 167.10 7.83
WAIST 571 74.40 224.79 122.46 15.17
HIP 570 67.00 276.00 148.59 17.80
WHR 569 .61 1.46 .83 .09
AGE 583 18 64 41.06 9.42
AGEONSET
2 460 1 55 13.96 8.98
Controls
537 females, 8 males
BMI 545 15.99 24.93 20.77 1.79
%FAT 535 7.50 40.00 23.66 5.61
WEIGHT 544 37.50 90.00 55.55 6.66
HEIGHT 544 133.90 194.00 163.43 6.82
WAIST 544 40.20 100.00 72.78 5.74
HIP 544 56.90 110.30 86.84 6.94
WHR 543 .50 1.33 .84 .07
AGE 545 16 65 42.64 8.75
Fathers
1
BMI 400 14.68 71.89 28.66 7.27
%FAT 326 3.30 59.20 25.97 8.53
WEIGHT 378 45.46 252.27 89.77 23.93
HEIGHT 375 153.70 198.12 176.89 7.12
WAIST 359 79.00 169.00 102.14 12.86
HIP 357 58.00 167.40 106.00 14.59
WHR 356 .72 1.66 .97 .07
AGE 400 42 95 66.74 9.85
AGEONSET
2 152 1.0 74.0 40.93 18.37
Mothers
1
BMI 411 15.94 69.02 32.77 10.37
%FAT 338 14.70 63.30 40.69 9.39
WEIGHT 392 40.45 185.23 87.76 28.53
HEIGHT 389 142.50 181.60 163.55 6.62
WAIST 380 61.80 159.00 96.97 19.91
HIP 379 60.40 174.90 116.21 21.42
WHR 379 .67 1.54 .83 .08
AGE 411 41 90 63.47 9.77
AGEONSET
2 247 .5 79.0 30.23 19.60
Sisters
BMI 278 17.01 77.58 34.34 11.23
%FAT 233 15.60 59.90 39.94 11.10
WEIGHT 268 45.68 212.95 94.74 31.57
HEIGHT 266 135.60 185.40 166.02 6.93
WAIST 260 60.90 165.80 97.48 21.45
HIP 260 75.50 202.30 118.43 25.21
WHR 260 .63 1.02 .82 .06
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also represents an example where enrichment of extreme cases
and controls can lead to increased odds ratio, and subsequently
leads to improved power to detect associations.
The association between waist to hip ratio and the NRXN3 gene
is of interest, as this is the third time the gene has been associated
with body fat distribution [12,13]. Neurexins are expressed in
nervous tissue and are thought to be involved in cell adhesion
during synapse formation [19]. Besides fat distribution, NRXN3
has been associated with several other traits, including addictions
and schizophrenia [20–22]. Identifying the specific causal variant
may be difficult because NRXN3 is an extremely large gene
(,1.5 Mb) [19]. It is controlled by two promoters and has multiple
transcripts. The SNPs associated with weight and fat distribution
lie in different parts of the gene and will likely involve different
transcripts with potentially different functions. The associated SNP
in our study, rs11624704, appears to be about 85 kb upstream of
the first exon, while those for the previous two studies, rs10150332
and rs10146997, appear to be about 8 kb apart near exon 11.
In conclusion, we have assayed a sample collection of obese
cases, families and never-overweight controls, and performed
association analysis on obesity and multiple quantitative pheno-
type measures. We obtained strong support for FTO as well as
suggestive confirmation of several previously identified BMI-
associated genes in obesity. Another outcome of our study is the
identification of new candidate genes for obesity-related traits. Of
particular interest is the association of NRXN3 with body fat
distribution among extremely obese individuals.
Materials and Methods
Study participants
The current GWAS study includes 520 cases and 540 control
subjects, who were non-Hispanic Caucasians. Cases were obese
(BMI$35 kg/m
2) with a lifetime BMI.40 kg/m
2. Among them,
32 were male while the rest were female subjects. Independent
controls were selected who had a current and lifetime
BMI#25 kg/m
2. The individuals in the samples were of
approximately the same age but differed in average BMI by
29 kg/m
2 (Table 1). After performing the GWAS, a combined
sample of cases, controls and family members (N=2,256),
including all the study participants in the GWAS, were included
for genotyping the top ,500 most significant SNPs based on
genotyping budget. Subject characteristics of family members were
shown in Table 2. Note that this is a study originally designed for
investigating obesity genes in female subjects, but over time we
have included a small fraction of males during the recruitment. All
subjects gave written informed consent, and the protocol was
approved by the Committee on Studies Involving Human Beings
at the University of Pennsylvania.
Phenotype measures
Anthropomorphic phenotypes were directly measured in field
settings. Percent fat was estimated using a bioelectric impedance
N Minimum Maximum Mean SD
AGE 278 14 64 37.81 9.22
AGEONSET
2 172 1.0 48.0 18.83 9.62
brothers
BMI 90 20.99 64.82 33.67 8.08
%FAT 79 4.10 49.90 29.78 9.54
WEIGHT 89 67.05 210.11 110.27 27.48
HEIGHT 88 164.60 197.60 180.48 6.59
WAIST 88 73.10 167.00 109.44 16.65
HIP 88 80.90 175.40 112.97 16.43
WHR 88 .80 1.35 .97 .08
AGE 90 15 60 38.67 9.33
AGEONSET
2 46 .5 45.0 22.76 10.82
1Some obese parents (BMI.40 kg/m
2) were selected as cases in Stage 1. All
cases were independent and from different families.
2AGEONSET refers to the age of onset for the obesity diagnosis.
doi:10.1371/journal.pone.0018939.t002
Table 2. Cont.
Table 3. Top association results (P,5610
28) for GWAS on obesity.
SNP Chr Position Closest Gene
SNP-gene
distance
MAF
(case)
MAF
(control) P-value
Odds
ratio
P-value
(case+control+family)
rs3751812 16 52375961 FTO 0 0.4836 0.3632 2.01610
28 1.642 4.2610
212
rs8050136 16 52373776 FTO 0 0.4846 0.3657 3.01610
28 1.631 4.7610
212
rs9941349 16 52382989 FTO 0 0.499 0.3826 6.53610
28 1.607 6.1610
211
rs9930333 16 52357478 FTO 0 0.5144 0.3983 7.90610
28 1.6 2.0610
211
rs10852521 16 52362466 FTO 0 0.4088 0.5166 6.34610
27 0.647 1.4610
211
rs10891096 11 109767953 FDX1 38 kb 0.0904 0.0383 1.03610
26 2.494 0.0045
rs7190492 16 52386253 FTO 0 0.3064 0.4067 1.46610
26 0.644 7.8610
29
rs8044769 16 52396636 FTO 0 0.4117 0.5139 2.36610
26 0.662 4.9610
210
rs9813516 3 60268044 FHIT 0 0.3004 0.2127 4.34610
26 1.59 N/A
rs7697609 4 40651331 APBB2 0 0.2587 0.1766 4.71610
26 1.627 0.11
rs6857327 4 40649029 APBB2 0 0.2658 0.1848 7.76610
26 1.597 0.14
rs3912607 3 163981452 OTOL1 1.3 Mb 0.3721 0.4677 8.34610
26 0.675 N/A
rs6921953 6 16127094 MYLIP 110 kb 0.0212 0.0594 9.13610
26 0.344 0.00054
rs247916 5 87566009 TMEM161B 0 0.1965 0.2787 9.15610
26 0.633 0.0022
doi:10.1371/journal.pone.0018939.t003
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study is described in Table 1 and Figure S1. Body mass index
was calculated from measured height and weight by the standard
formula, Weight (kg) divided by Height (m
2). Measurements were
taken of subjects dressed in light clothing. Height was measured
from a standing position using a stadiometer. Weight was
measured by a scale with a maximum weight of 600 pounds
(270 kg) (Tanita TBF310 Pro Body Composition Analyzer,
Tanita, Arlington Heights, IL). Body composition was estimated
by bioelectric impedance using the same Tanita scale. Waist
circumference was measured while standing at the height of the
iliac crest. Hip circumference was taken while standing at the
maximum extension of the buttocks. Waist to hip ratio (WHR) was
calculated by measured waist circumference divided by measured
hip circumference. Age of Obesity Onset was the age at which the
subject reported having first become overweight.
Genotyping
DNA was extracted from whole blood or lymphoblastoid cell
lines using a high salt method. All cases and control subjects were
genotyped on the Illumina HumanHap550 SNP arrays (Illumina,
San Diego, CA) with ,550,000 SNP markers, at the Center for
Applied Genomics, Children’s Hospital of Philadelphia. Standard
data normalization procedures and canonical genotype clustering
files were used to process the genotyping signals and generate
genotype calls. In addition, the combined sample of cases, controls
and family members (N=2,256, Table 2) were genotyped for the
top 500 SNPs from the GWAS using the Illumina ISelect
platform. All cases, family members, and controls were non-
Hispanic Caucasians, and we further utilized multi-dimensional
scaling to confirm the ethnicity status of cases and control subjects.
A subset of the whole-genome genotype data were previously
described in a CNV study on obesity [23].
Association analysis
The PLINK software version 1.07 was used to conduct
association tests between SNP genotypes and specific phenotypes
of interest. For traits that are approximately normally distributed,
we utilized standard linear regression for assessing association but
including age, sex and disease status as covariates. We attempted
to exclude samples with genotyping rate less than 95% but none of
the samples met this criterion. SNPs were excluded in analysis if
the minor allele frequency was less than 1% (23298 SNPs were
excluded), or if the Hardy-Weinberg Equilibrium P-value was less
Table 4. Most significantly associated SNPs in the combined
case/control and family cohort.
SNP Chr Loc Closest Gene P(MQLS)
rs17817449 16 52370868 FTO 2.35610
212
rs3751812 16 52375961 FTO 4.22610
212
rs9935401 16 52374339 FTO 4.36610
212
rs8050136 16 52373776 FTO 4.71610
212
rs1121980 16 52366748 FTO 9.50610
212
rs10852521 16 52362466 FTO 1.38610
211
rs1861866 16 52361841 FTO 1.41610
211
rs9937053 16 52357008 FTO 1.56610
211
rs9930333 16 52357478 FTO 2.02610
211
rs9931494 16 52384680 FTO 4.24610
211
rs9941349 16 52382989 FTO 6.08610
211
rs8044769 16 52396636 FTO 4.86610
210
rs7206790 16 52355409 FTO 6.08610
210
rs1477196 16 52365759 FTO 9.33610
29
rs7190492 16 52386253 FTO 9.79610
29
rs3751813 16 52376209 FTO 1.63610
28
rs16867321 2 181070624 UBE2E3 1.63610
26
rs2887180 2 181157550 UBE2E3 2.44610
26
rs4784323 16 52355066 FTO 3.88610
26
rs925642 4 187915860 FAT1/MTNR1A 7.37610
26
The associated tests were performed by MQLS.
doi:10.1371/journal.pone.0018939.t004
Table 5. List of significant associations (P,1610
26) in quantitative trait analyses.
phenotype Chr SNP Pos Gene SNP-Gene distance P (adjusting for obesity)
BMI 8 rs17126232 18021930 ASAH1 35143 3.62610
27
BMI 8 rs17126237 18025369 ASAH1 38582 5.57610
27
HIP 7 rs10953454 104291049 LHFPL3 0 7.20610
27
HIP 7 rs10216243 104300860 LHFPL3 0 8.07610
27
HIP 8 rs17126232 18021930 ASAH1 35143 1.50610
27
HIP 8 rs17126237 18025369 ASAH1 38582 3.45610
27
HIP 16 rs9923451 77509940 WWOX 0 7.95610
27
HIP 22 rs5762430 26708472 PITPNB 63217 7.32610
27
Waist 21 rs11088859 21611215 NCAM2 0 3.75610
28
Weight 8 rs17126232 18021930 ASAH1 35143 8.28610
28
Weight 8 rs17126237 18025369 ASAH1 38582 8.74610
28
Weight 13 rs17081231 65865623 PCDH9 0 7.18610
27
WHR 2 rs7581710 120911651 INHBB 85798 2.12610
27
WHR 6 rs2807278 131851613 ARG1 84445 3.18610
27
WHR 14 rs11624704 77855830 NRXN3 84016 2.67610
29
doi:10.1371/journal.pone.0018939.t005
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26 in control subjects (1366 SNPs were excluded), or if
the genotype missing rate is higher than 5% (8190 SNPs were
excluded). The study participants are of European ancestry as
evaluated in previous studies [24]; given whole-genome data, we
also performed multi-dimensional scaling analysis on SNPs not in
LD (r
2,0.2) with each other and confirmed that all cases and
control subjects were of genetically inferred European ancestry
(Figure S2). The QQ plot for the obesity GWAS is given in
Figure S3, and the genomic control inflation factor was 1.05.
The combined dataset of cases, family members and controls
was next analyzed using MQLS. MQLS utilizes a quasi-likelihood
score test approach developed by Thornton and McPeek [25] that
treats the data as a case-control analysis consisting of related and
unrelated individuals. This combined approach has substantially
more power than separate analyses using either case-control or
family based methods. However, we acknowledge that since the
candidate SNP genotyping study is not independent of the GWAS,
the P-value distributions will be biased and therefore our study
cannot be regarded as a standard ‘‘2-stage’’ analysis. The MQLS
(b) statistic incorporates parental data in the estimation of case
genotypes. We restricted these analyses to obesity status, since the
method currently is adapted only for dichotomous phenotypes.
Supporting Information
Figure S1 The distribution of phenotype measures utilized in
the current study. The age of onset information is available for
cases only. BMI, weight, BIA and waist have bi-modal
distribution, so we explored testing on cases only.
(PDF)
Figure S2 Multi-dimensional scaling (MDS) of the SNP
genotyping data for samples with whole-genome genotypes, with
(left panel) or without (right panel) 30 Asian, 30 African American
and 30 Caucasians to seed the graph. A total of 70,593 SNPs not
in LD (r
2,0.2) and not in sex chromosomes were used in the MDS
analysis. All GWAS samples were of genetically inferred European
ancestry.
(PDF)
Figure S3 The quantile-quantile (QQ) plot of the association
results for the GWAS on obesity. The genomic control inflation
factor was 1.05.
(PDF)
Table S1 Examination of BMI-associated genes in our data set
for association with quantitative traits in cases and controls,
adjusting for obesity status.
(PDF)
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